CUBE vs DERM · P/E 25, rev $1.07B vs rev $56.1M
CubeSmart (CUBE) versus Journey Medical Corp (DERM) — a side-by-side from cached financials, not a winner call.
CubeSmart (CUBE) is a reit - industrial company listed on US.
Journey Medical Corp (DERM) is a drug manufacturers - specialty & generic company listed on US.
Latest reported CUBE revenue for 2024-12-31 was $1.07B. Net income was $391.9M. Revenue was up 1.5% from 2023-12-31 to 2024-12-31. CUBE currently screens at market cap $9.69B and trailing P/E 25.0.
Latest reported DERM revenue for 2024-12-31 was $56.1M. Net income was -$14.7M. Revenue was down 29.1% from 2023-12-31 to 2024-12-31. DERM currently screens at market cap $163.1M.
CUBE currently screens at market cap $9.69B and trailing P/E 25.0. DERM currently screens at market cap $163.1M.
Not investment advice. Open the CUBE and DERM stock pages for the full models.
Not investment advice.